The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
An update on the global disparities in kidney disease burden and care across world countries and regions
Open accessAbstract
BACKGROUND: Since 2015, the International Society of Nephrology (ISN) Global Kidney Health Atlas (ISN-GKHA) has spearheaded multinational efforts to understand the status and capacity of countries to provide optimal kidney care, particularly in low-resource settings. In this iteration of the ISN-GKHA, we sought to extend previous findings by assessing availability, accessibility, quality, and affordability of medicines, kidney replacement therapy (KRT), and conservative kidney management (CKM). METHODS: A consistent approach was used to obtain country-level data on kidney care capacity during three phases of data collection in 2016, 2018, and 2022. The current report includes a detailed literature review of published reports, databases, and registries to obtain information on the burden of chronic kidney disease and estimate the incidence and prevalence of treated kidney failure. Findings were triangulated with data from a multinational survey of opinion leaders based on the WHO's building blocks for health systems (ie, health financing, service delivery, access to essential medicines and health technology, health information systems, workforce, and governance). Country-level data were stratified by the ISN geographical regions and World Bank income groups and reported as counts and percentages, with global, regional, and income level estimates presented as medians with interquartile ranges. FINDINGS: The literature review used information on prevalence of chronic kidney disease from 161 countries. The global median prevalence of chronic kidney disease was 9·5% (IQR 5·9-11·7) with the highest prevalence in Eastern and Central Europe (12·8%, 11·9-14·1). For the survey analysis, responses received covered 167 (87%) of 191 countries, representing 97·4% (7·700 billion of 7·903 billion) of the world population. Chronic haemodialysis was available in 162 (98%) of 165 countries, chronic peritoneal dialysis in 130 (79%), and kidney transplantation in 116 (70%). However, 121 (74%) of 164 countries were able to provide KRT to more than 50% of people with kidney failure. Children did not have access to haemodialysis in 12 (19%) of 62 countries, peritoneal dialysis in three (6%) countries, or kidney transplantation in three (6%) countries. CKM (non-dialysis management of people with kidney failure chosen through shared decision making) was available in 87 (53%) of 165 countries. The annual median costs of KRT were: US$19 380 per person for haemodialysis, $18 959 for peritoneal dialysis, and $26 903 for the first year of kidney transplantation. Overall, 74 (45%) of 166 countries allocated public funding to provide free haemodialysis at the point of delivery; use of this funding scheme increased with country income level. The median global prevalence of nephrologists was 11·8 per million population (IQR 1·8-24·8) with an 80-fold difference between low-income and high-income countries. Differing degrees of health workforce shortages were reported across regions and country income levels. A quarter of countries had a national chronic kidney disease-specific strategy (41 [25%] of 162) and chronic kidney disease was recognised as a health priority in 78 (48%) of 162 countries. INTERPRETATION: This study provides new information about the global burden of kidney disease and its treatment. Countries in low-resource settings have substantially diminished capacity for kidney care delivery. These findings have major policy implications for achieving equitable access to kidney care. FUNDING: International Society of Nephrology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
Self-citationEysenbach, G. (2004) · Journal of Medical Internet Research · doi:10.2196/jmir.6.3.e34 · Cited by 6,480
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
Stevens, G. A., Alkema, L., Black, R. E., Boerma, J. T., Collins, G. S., Ezzati, M., Grove, J. T., Hogan, D. R., Hogan, M. C., Horton, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30388-9 · Cited by 1,798
Jager, K. J., Kovesdy, C., Langham, R., Rosenberg, M., Jha, V., & Zoccali, C. (2019) · Kidney International · doi:10.1016/j.kint.2019.07.012 · Cited by 957
Self-citationGlobal kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
Levin, A., Tonelli, M., Bonventre, J., Coresh, J., Donner, J.-A., Fogo, A. B., Fox, C. S., Gansevoort, R. T., Heerspink, H. J. L., Jardine, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30788-2 · Cited by 919
Self-citationDavison, S. N., Levin, A., Moss, A. H., Jha, V., Brown, E. A., Brennan, F., Murtagh, F. E. M., Naicker, S., Germain, M. J., O'Donoghue, D. J., et al. (2015) · Kidney International · doi:10.1038/ki.2015.110 · Cited by 580
Self-citationAssessment of Global Kidney Health Care Status
Bello, A. K., Levin, A., Tonelli, M., Okpechi, I. G., Feehally, J., Harris, D., Jindal, K., Salako, B. L., Rateb, A., Osman, M. A., et al. (2017) · JAMA · doi:10.1001/jama.2017.4046 · Cited by 487
Self-citationReducing the costs of chronic kidney disease while delivering quality health care: a call to action
on behalf of the European Kidney Health Alliance, Vanholder, R., Annemans, L., Brown, E., Gansevoort, R., Gout-Zwart, J. J., Lameire, N., Morton, R. L., Oberbauer, R., Postma, M. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.63 · Cited by 368
Self-citationChronic kidney disease in low- and middle-income countries
Stanifer, J. W., Muiru, A., Jafar, T. H., & Patel, U. D. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv466 · Cited by 341
Bello, A. K., Levin, A., Lunney, M., Osman, M. A., Ye, F., Ashuntantang, G. E., Bellorin-Font, E., Benghanem Gharbi, M., Davison, S. N., Ghnaimat, M., et al. (2019) · BMJ · doi:10.1136/bmj.l5873 · Cited by 280
Self-citation
Cited by
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Lübker, C., Bhavsar, J., Duque do Vale, R., Emerson, S. S., Nørtoft, E., Plutzky, J., Roberts, G., Tarp, J. M., & Lincoff, A. M. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03176-w · Cited by 5
Metadata
- Authors
- Bello, A. K., Okpechi, I. G., Levin, A., Ye, F., Damster, S., Arruebo, S., Donner, J.-A., Caskey, F. J., Cho, Y., Davids, M. R., Davison, S. N., Htay, H., Jha, V., Lalji, R., Malik, C., Nangaku, M., See, E., Sozio, S. M., Tonelli, M., Wainstein, M., Yeung, E. K., Johnson, D. W., Abu-Alfa, A. K., Amouzegar, A., Anand, S., Arogundade, F. A., Ashuntantang, G. E., Bavanandan, S., Coppo, R., Diongole, H. M., Divyaveer, S., Ekrikpo, U. E., Ethier, I., Fung, W. W.-S., Gaipov, A., Ghimire, A., Houston, G., Ibrahim, K. S., Irish, G., Jindal, K., Kelly, D. M., Lightstone, L., Madero, M., Nalado, A. M., Neuen, B. L., Olanrewaju, T. O., Osman, M. A., Parekh, R. S., Petrova, A., Prasad, N., Prikhodina, L., Racki, S., Riaz, P., Saad, S., Sakajiki, A. M., Savaj, S., Singh Shah, D., Suzuki, Y., Tesar, V., Tiv, S., Tungsanga, S., Tzanno-Martins, C., Viecelli, A., Wang, A. Y.-M., Wong, M. G., & Zaidi, D.
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2024-03
- Volume
- 12
- Issue
- 3
- Pages
- e382-e395
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W4392145600
- Cited by
- 522
- References
- 20
- FWCI
- 129.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An update on the global disparities in kidney disease burden and care across world countries and regions. https://app.cochat.ai/papers/10.1016/s2214-109x(23)00570-3
- The paper
- Bello, A. K., Okpechi, I. G., Levin, A., Ye, F., Damster, S., Arruebo, S., Donner, J.-A., Caskey, F. J., Cho, Y., Davids, M. R., Davison, S. N., Htay, H., Jha, V., Lalji, R., Malik, C., Nangaku, M., See, E., Sozio, S. M., Tonelli, M., . . . Zaidi, D. (2024). An update on the global disparities in kidney disease burden and care across world countries and regions. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(23)00570-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.